EXELIXIS INC (EXEL) Stock Analyst Ratings
NASDAQ:EXEL • US30161Q1040
44.01 USD
+0.38 (+0.87%)
At close: Feb 23, 2026
44.01 USD
0 (0%)
After Hours: 2/23/2026, 8:00:03 PM
ChartMill assigns a Buy % Consensus number of 75% to EXEL. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 46.75. This target is 6.23% above the current price.
- EXEL was analyzed by 27 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about EXEL.
- In the previous month the buy percentage consensus was at a similar level.
- EXEL was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-02-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-11 | Stifel | Maintains | Hold -> Hold |
| 2026-02-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-02-02 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-08 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2026-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-03 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-10-21 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-10-21 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-10-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-17 | Barclays | Initiate | Equal-Weight |
| 2025-09-17 | Goldman Sachs | Initiate | Buy |
| 2025-09-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-30 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-29 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-07-29 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-07-29 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-07-29 | Stifel | Maintains | Hold -> Hold |
| 2025-07-29 | Truist Securities | Maintains | Buy -> Buy |
EXELIXIS INC / EXEL FAQ
Can you provide the average price target for EXELIXIS INC stock?
27 analysts have analysed EXEL and the average price target is 46.75 USD. This implies a price increase of 6.23% is expected in the next year compared to the current price of 44.01.
How do analysts rate EXELIXIS INC (EXEL)?
The consensus rating for EXELIXIS INC (EXEL) is 74.8148 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for EXEL stock?
The number of analysts covering EXELIXIS INC (EXEL) is 27.